CNSY
Plus Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$1.65
−2.94%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-56.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 1, 2026 | van Es-Johansson An · director | M-Exempt | 921 | $0.00 |
| Oct 1, 2026 | Hawkins Richard J · director | M-Exempt | 921 | $0.00 |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre · officer: Chief Financial Officer | M-Exempt | 1,533 | $0.00 |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre · officer: Chief Financial Officer | M-Exempt | 1,165 | $0.00 |
| Oct 1, 2026 | Sims Andrew John Hugh MacIntyre · officer: Chief Financial Officer | M-Exempt | 287 | $0.00 |
| Oct 1, 2026 | Clowes Howard · director | M-Exempt | 921 | $0.00 |
| Oct 1, 2026 | ANDREWS RONALD ASBURY · director | M-Exempt | 921 | $0.00 |
| Oct 1, 2026 | HEDRICK MARC H · director, officer: Chief Executive Officer | M-Exempt | 6,387 | $0.00 |
| Oct 1, 2026 | HEDRICK MARC H · director, officer: Chief Executive Officer | M-Exempt | 8,066 | $0.00 |
| Oct 1, 2026 | HEDRICK MARC H · director, officer: Chief Executive Officer | M-Exempt | 1,986 | $0.00 |
| Oct 1, 2026 | Guse Kyle · director | M-Exempt | 921 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 1, 2026